Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial

INTRODUCTION: HIV infection and certain antiretroviral therapy (ART) medications increase atherosclerotic cardiovascular disease risk, mediated, in part, through traditional cardiovascular disease risk factors. METHODS AND RESULTS: We studied cardiovascular disease risk factor changes in the START (...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Jason V., Sharma, Shweta, Achhra, Amit C., Bernardino, Jose Ignacio, Bogner, Johannes R., Duprez, Daniel, Emery, Sean, Gazzard, Brian, Gordin, Jonathan, Grandits, Greg, Phillips, Andrew N., Schwarze, Siegfried, Soliman, Elsayed Z., Spector, Stephen A., Tambussi, Giuseppe, Lundgren, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524070/
https://www.ncbi.nlm.nih.gov/pubmed/28533305
http://dx.doi.org/10.1161/JAHA.116.004987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524070/
https://www.ncbi.nlm.nih.gov/pubmed/28533305
http://dx.doi.org/10.1161/JAHA.116.004987

Ejemplares similares